| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 348 |
| 1 | DEXAMETHASONE 1.5 MG | 347 |
| 2 | PREDNISONE | 295 |
| 3 | CYCLOPHOSPHAMIDE | 272 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 272 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 272 |
| 6 | CYTARABINE | 247 |
| 7 | TACROLIMUS | 247 |
| 8 | METHOTREXATE SODIUM | 238 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 222 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 65 | 0.0078 |
| 1 | DECITABINE | 31 | 0.0071 |
| 2 | PEGASPARGASE | 64 | 0.0052 |
| 3 | CYTARABINE | 247 | 0.0041 |
| 4 | CARMUSTINE | 19 | 0.0040 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 23 | 0.0037 |
| 6 | CLINDAMYCIN PHOSPHATE | 20 | 0.0036 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 26 | 0.0032 |
| 8 | FILGRASTIM | 121 | 0.0032 |
| 9 | MICAFUNGIN SODIUM | 21 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 839 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 412 |
| 2 | Alkylating Drug [EPC] | 359 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 282 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 224 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 221 |
| 6 | Platinum-based Drug [EPC] | 174 |
| 7 | Benzodiazepine [EPC] | 165 |
| 8 | Leukocyte Growth Factor [EPC] | 153 |
| 9 | Proton Pump Inhibitor [EPC] | 152 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 8 | 0.0079 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 44 | 0.0075 |
| 3 | Asparagine-specific Enzyme [EPC] | 73 | 0.0054 |
| 4 | CD22-directed Immunoconjugate [EPC] | 16 | 0.0053 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 9 | 0.0037 |
| 6 | CD33-directed Immunoconjugate [EPC] | 13 | 0.0035 |
| 7 | Carnitine Analog [EPC] | 12 | 0.0033 |
| 8 | Echinocandin Antifungal [EPC] | 26 | 0.0032 |
| 9 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |